This document provides a synopsis of the remarks made by Jennifer Brant, the executive director of Innovation Council, at the TRIPS Council Special Session in September of 2023. Jennifer discusses three of her most prominent works: Unprecedented (2021, co-authored with Prof. Mark Schultz), Making Biologics (2022), and Biomanufacturing Resilience (2023). She noted that the topic of the Special Session – extension of the 2022 TRIPS decision – is really about ensuring adequate health products supply and extending biomanufacturing capacity, for health security.
Jennifer spoke in her personal capacity.
Click here to read the synopsis of her remarks.
This document provides a synopsis of the remarks made by Jennifer Brant, the executive director of Innovation Council, at the TRIPS Council Special Session in September of 2023. Jennifer discusses three of her most prominent works: Unprecedented (2021, co-authored with Prof. Mark Schultz), Making Biologics (2022), and Biomanufacturing Resilience (2023). She noted that the topic of the Special Session – extension of the 2022 TRIPS decision – is really about ensuring adequate health products supply and extending biomanufacturing capacity, for health security.
Jennifer spoke in her personal capacity.
Click here to read the synopsis of her remarks.